Among them, Fucobacterium nucleatum is mostly associated with CpG island methylator phenotype, microsatellite instability, and BRAF, KRAS, TP53, CHD7, and CHD8 mutations, which are suggested to predispose mortality related to CRC and worse clinical outcomes [57–59]. This evidence concerns the gene TP53 and colorectal carcinoma.